Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2021

View Archived Issues

rVSV-deltaG-spike vaccine protects hamsters against SARS-CoV-2 challenge

Forma begins phase II/III study of FT-4202 in sickle cell disease

Viralym-M enters phase III for virus-associated hemorrhagic cystitis

Dyne reports preclinical data from DM1 program

Chinese investigators divulge EGFR inhibitors

Nanjing Greepharma patents new ARG1 inhibitors

Shanghai Institute of Materia Medica discloses PRDX1 inhibitors

Hawaii Biotech identified new botulinum neurotoxin inhibitors

DalCor initiates phase II study of dalcetrapib in patients with COVID-19

Turning Point Therapeutics describes new RET inhibitors

Antibody protects broadly against flaviviruses, without ADE

A humanized mouse HIV latency model to test HIV cure strategies

Promising data presented from global phase III study with valoctocogene roxaparvovec in hemophilia A

Identification of small-molecule HNC-0014 as a multi-targeted immunotherapy lead compound for HNSCC

New heterocyclic ring systems as a novel class of brain-penetrating V1A antagonists

Chipscreen Biosciences submits IND to the NMPA for pivotal phase III study of chiauranib in SCLC

Leishmania parasites trigger SHP-1, which acts as a negative regulator of antigen cross-presentation

Axcella provides development updates for its lead candidates

European Commission approves Roclanda ophthalmic solution

Promising data presented from phase II study of rifamycin SV-MMX in IBS-D

Gannex reports phase I data on ASC-41 supporting progression for NASH

Helsinn begins phase I/II study of oral RET inhibitor TAS-0953 in advanced solid tumors

CureVac reports NHP data on COVID-19 vaccine candidate CVnCoV

New trial investigates use of NAC for IPF

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...